A controlled double-blind crossover study of the efficacy of mepiprazol (EMD 16.923) and of diazepam in the treatment of neurotic disorders
De Buck, R.; Van Durme, R.; Pelc, I.
Acta Psychiatrica Belgica 75(3): 320-333
1975
ISSN/ISBN: 0300-8967 PMID: 769484 Document Number: 86339
After a preliminary encouraging trial of mepiprazol (EMD 16.923) on 8 patients, a double-blind cross-over study of mepiprazol and diazepam was performed in order to compare their effect in the treatment of neurotic disorders, particularly on various forms of anxiety.
Document emailed within 1 workday
Related Documents
Bozza, A.E.; Guimarães, F.J.; de Carvalho, F.J.; Santos, L.C.; Pellon, F.M.; de Castro, R.F.; Balbuena, R.R. 1984: Comparative double-blind, randomized, crossover study controlled with placebo, of the efficacy of depot nifedipine in patients refractory to basic antihypertensive therapy Arquivos Brasileiros de Cardiologia 43(3): 213-217Langrick, A.F.; Gunn, A.D.; Livesey, H.; Whitehead, A.M. 1989: A double-blind placebo-controlled crossover study of mebeverine and mefenamic acid in the treatment of primary dysmenorrhoea British Journal of Clinical Practice 43(9): 317-321
Clerico, M.; Bertetto, O.; Morandini, M.P.; Cardinali, C.; Giaccone, G. 1993: Antiemetic activity of oral lorazepam in addition to methylprednisolone and metoclopramide in the prophylactic treatment of vomiting induced by cisplatin. A double-blind, placebo-controlled study with crossover design Tumori 79(2): 119-122
Herzog, J.L.; Solomon, J.A.; Draelos, Z.; Fleischer, A.; Stough, D.; Wolf, D.I.; Abramovits, W.; Werschler, W.; Green, E.; Duffy, M.; Rothaul, A.; Tansley, R. 2011: A randomized, double-blind, vehicle-controlled crossover study to determine the anti-pruritic efficacy, safety and local dermal tolerability of a topical formulation (srd174 cream) of the long-acting opiod antagonist nalmefene in subjects with atopic dermatitis Journal of Drugs in Dermatology: Jdd 10(8): 853-860
Voigt, U.; Klassen, E. 1982: Testing of ketoprofen for interaction with oral antidiabetics. a double-blind controlled clinical crossover study Die Medizinische Welt 33(45): 1592-1593
Karniol, I.G.; Portela, W. 1982: Oxprenolol in schizophrenic patients with tardive dyskinesia: a double-blind placebo-controlled, crossover study Brazilian Journal of Medical and Biological Research 15(6): 389-394
Soonthornpun, S.; Rattarasarn, C.; Thamprasit, A.; Leetanaporn, K. 1998: Effect of acarbose in treatment of type Ii diabetes mellitus: a double-blind, crossover, placebo-controlled trial Journal of the Medical Association of Thailand 81(3): 195-200
Horak, F.; Matthes, H. 1982: The protective action of fluocortin butylester (FCB) in the nasal antigen provocation test: a controlled double-blind, crossover study Annals of Allergy 48(5): 305-308
Moldofsky, H.; Lue, F.A.; Mously, C.; Roth-Schechter, B.; Reynolds, W.J. 1996: The effect of zolpidem in patients with fibromyalgia: a dose ranging, double blind, placebo controlled, modified crossover study Journal of Rheumatology 23(3): 529-533
Young, S.A.; Hurt, P.H.; Benedek, D.M.; Howard, R.S. 1998: Treatment of premenstrual dysphoric disorder with sertraline during the luteal phase: a randomized, double-blind, placebo-controlled crossover trial Journal of Clinical Psychiatry 59(2): 76-80
Gulias-Herrero, A.; Aguilar-Salinas, C.A.; Gómez-Pérez, F.J.; Rull, J.A. 2003: The combination metformin/glyburide exerts its hypoglycemic effect mainly by increasing insulin secretion: a controlled, randomized, double-blind, crossover study Diabetes Nutrition and Metabolism 16(5-6): 268-276
Franke, W.; Bachert, C.; Messinger, D. 1989: Double-blind controlled crossover study comparing the protective effect of picumast dihydrochloride versus placebo following nasal allergen challenge Arzneimittel-Forschung 39(10a): 1354-1356
Parish, L.C.; Parish, J.L.; Routh, H.B.; Fleischer, A.B.; Avakian, E.V.; Plaum, S.; Hardas, B. 2011: A randomized, double-blind, vehicle-controlled efficacy and safety study of naftifine 2% cream in the treatment of tinea pedis Journal of Drugs in Dermatology: Jdd 10(11): 1282-1288
Habrat, B.ła.; Załoga, B. 2006: A double-blind controlled study of the efficacy and acceptability of tianeptine in comparison with fluvoxamine in the treatment of depressed alcoholic patients Psychiatria Polska 40(3): 579-597
Miyamoto, S. 1972: Evaluation of a new minor tranquilizer, Y-6047, for preanesthetic medication--comparison with a placebo and diazepam by a double blind controlled study Masui. Japanese Journal of Anesthesiology 21(8): 787-795
Fauvel, J.P.; Najem, R.; Maakel, N.; Pozet, N.; Laville, M. 1998: Effects of moxonidine on stress-induced peak blood pressure and renal function: a randomized, double-blind, placebo-controlled crossover study Journal of Cardiovascular Pharmacology 32(3): 495-499
Brügmann, U.; Blasini, R.; Rudolph, W. 1983: Anti-ischemic effect of nifedipine in delayed-action form. Results of a double-blind, randomized, crossover, placebo-controlled acute study Herz 8(4): 206-210
Berlin, J.M.; Eisenberg, D.P.; Berlin, M.B.; Sarro, R.A.; Leeman, D.R.; Fein, H. 2011: A randomized, placebo-controlled, double-blind study to evaluate the efficacy of a citrus bioflavanoid blend in the treatment of senile purpura Journal of Drugs in Dermatology: Jdd 10(7): 718-722
Trnavský, K.; Fischer, M.; Vögtle-Junkert, U.; Schreyger, F. 2004: Efficacy and safety of 5% ibuprofen cream treatment in knee osteoarthritis. Results of a randomized, double-blind, placebo-controlled study Journal of Rheumatology 31(3): 565-572
Miller, W.C.; McCurdy, L. 1984: A double-blind comparison of the efficacy and safety of lorazepam and diazepam in the treatment of the acute alcohol withdrawal syndrome Clinical Therapeutics 6(3): 364-371